1. Home
  2. IDN vs CCCC Comparison

IDN vs CCCC Comparison

Compare IDN & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDN
  • CCCC
  • Stock Information
  • Founded
  • IDN 1994
  • CCCC 2015
  • Country
  • IDN United States
  • CCCC United States
  • Employees
  • IDN N/A
  • CCCC N/A
  • Industry
  • IDN Computer Software: Prepackaged Software
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • IDN Technology
  • CCCC Health Care
  • Exchange
  • IDN Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • IDN 101.6M
  • CCCC 104.4M
  • IPO Year
  • IDN 1999
  • CCCC 2020
  • Fundamental
  • Price
  • IDN $5.02
  • CCCC $2.46
  • Analyst Decision
  • IDN Strong Buy
  • CCCC Buy
  • Analyst Count
  • IDN 3
  • CCCC 2
  • Target Price
  • IDN $6.17
  • CCCC $8.00
  • AVG Volume (30 Days)
  • IDN 194.3K
  • CCCC 1.5M
  • Earning Date
  • IDN 08-12-2025
  • CCCC 08-07-2025
  • Dividend Yield
  • IDN N/A
  • CCCC N/A
  • EPS Growth
  • IDN N/A
  • CCCC N/A
  • EPS
  • IDN N/A
  • CCCC N/A
  • Revenue
  • IDN $20,662,000.00
  • CCCC $34,240,000.00
  • Revenue This Year
  • IDN $9.35
  • CCCC N/A
  • Revenue Next Year
  • IDN $13.05
  • CCCC N/A
  • P/E Ratio
  • IDN N/A
  • CCCC N/A
  • Revenue Growth
  • IDN 7.12
  • CCCC 16.55
  • 52 Week Low
  • IDN $1.92
  • CCCC $1.09
  • 52 Week High
  • IDN $6.49
  • CCCC $7.22
  • Technical
  • Relative Strength Index (RSI)
  • IDN 48.83
  • CCCC 59.48
  • Support Level
  • IDN $4.88
  • CCCC $1.95
  • Resistance Level
  • IDN $5.50
  • CCCC $2.94
  • Average True Range (ATR)
  • IDN 0.28
  • CCCC 0.26
  • MACD
  • IDN -0.01
  • CCCC 0.00
  • Stochastic Oscillator
  • IDN 46.67
  • CCCC 51.52

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: